The Effect of FDA Drug Safety Communications on Patterns of Tiotropium Dispensing: A U.S. Health Plan Claims Database Study

BACKGROUND: The FDA issued 2 main drug safety communications (DSCs) on the cardiovascular safety of tiotropium in March 2008 (warning of a potential increased stroke risk) and January 2010 (informing of an absence of a significant increased stroke risk or cardiovascular events based on findings from...

Descripción completa

Detalles Bibliográficos
Autores principales: Major, Jacqueline M., Zhou, Esther H., Ding, Yulan, Ly, Thomas, Li, Jie, Pinheiro, Simone P., Seymour, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398184/
https://www.ncbi.nlm.nih.gov/pubmed/29952703
http://dx.doi.org/10.18553/jmcp.2018.24.7.700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398184/
https://www.ncbi.nlm.nih.gov/pubmed/29952703
http://dx.doi.org/10.18553/jmcp.2018.24.7.700

Ejemplares similares